Silverleafe Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
2,236
+88
| +4% | +$16.3K | 0.14% | 54 |
|
|
2025
Q1 | $450K | Buy |
2,148
+56
| +3% | +$11.7K | 0.15% | 55 |
|
|
2024
Q4 | $372K | Hold |
2,092
| – | – | 0.12% | 79 |
|
|
2024
Q3 | $413K | Buy |
2,092
+2
| +0.1% | +$395 | 0.14% | 55 |
|
|
2024
Q2 | $358K | Hold |
2,090
| – | – | 0.12% | 57 |
|
|
2024
Q1 | $381K | Hold |
2,090
| – | – | 0.15% | 50 |
|
|
2023
Q4 | $324K | Hold |
2,090
| – | – | 0.15% | 39 |
|
|
2023
Q3 | $312K | Hold |
2,090
| – | – | 0.16% | 39 |
|
|
2023
Q2 | $282K | Hold |
2,090
| – | – | 0.17% | 42 |
|
|
2023
Q1 | $333K | Buy |
2,090
+17
| +0.8% | +$2.71K | 0.21% | 40 |
|
|
2022
Q4 | $335K | Hold |
2,073
| – | – | 0.22% | 40 |
|
|
2022
Q3 | $278K | Hold |
2,073
| – | – | 0.18% | 51 |
|
|
2022
Q2 | $318K | Hold |
2,073
| – | – | 0.19% | 42 |
|
|
2022
Q1 | $336K | Hold |
2,073
| – | – | 0.15% | 49 |
|
|
2021
Q4 | $281K | Hold |
2,073
| – | – | 0.1% | 72 |
|
|
2021
Q3 | $224K | Sell |
2,073
-12
| -0.6% | -$1.3K | 0.09% | 73 |
|
|
2021
Q2 | $235K | Hold |
2,085
| – | – | 0.09% | 76 |
|
|
2021
Q1 | $226K | Buy |
2,085
+12
| +0.6% | +$1.3K | 0.09% | 81 |
|
|
2020
Q4 | $222K | Buy |
+2,073
| New | +$222K | 0.1% | 67 |
|
|
2020
Q3 | – | Sell |
-17,430
| Closed | -$1.71M | – | 64 |
|
|
2020
Q2 | $1.71M | Buy |
17,430
+13,583
| +353% | +$1.33M | 1.17% | 25 |
|
|
2020
Q1 | $293K | Buy |
3,847
+134
| +4% | +$10.2K | 0.35% | 30 |
|
|
2019
Q4 | $329K | Buy |
+3,713
| New | +$329K | 0.19% | 56 |
|